50 results on '"Wolfgang, Christopher L"'
Search Results
2. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
3. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
4. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations
5. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms
6. Hypermutation In Pancreatic Cancer
7. 83 UTILIZATION OF NEOADJUVANT THERAPY IN ELDERLY PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: AN NCDB STUDY
8. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
9. Sa1312: INCIDENCE AND PREDICTORS OF EARLY AND LATE READMISSION AFTER ACUTE PANCREATITIS
10. Mo1675: MANAGEMENT OF PERIPANCREATIC PERIPHERAL NERVE SHEATH (PPNS) TUMORS
11. 427: TAILORING ADJUVANT CHEMOTHERAPY TO BIOLOGIC RESPONSES FOLLOWING NEOADJUVANT CHEMOTHERAPY IMPACTS OVERALL SURVIVAL IN PANCREATIC CANCER
12. 681 EXERCISE STIMULATES ANTITUMORAL IMMUNITY IN PANCREATIC DUCTAL ADENOCARCINOMA
13. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
14. Sa299 NATURAL HISTORY OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS: A PROSPECTIVE STUDY
15. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
16. Su1154 WHEN SHOULD WE OPERATE ON PANCREATIC CYSTS DETECTED IN HIGH-RISK INDIVIDUALS (HRI)? VALIDATING PROPOSED CRITERIA FOR RESECTION USING INTERNATIONAL CONSENSUS GUIDELINES (ICG) AND INTERNATIONAL CANCER OF THE PANCREAS SCREENING (CAPS) CONSORTIUM STATEMENTS
17. 695 OMACETAXINE AS A POTENTIAL EFFECTIVE STRATEGY FOR HEPATOCELLULAR CARCINOMA
18. Su1145 TUMOR SIZE, TUMOR STAGE, AND SURVIVAL OF HIGH RISK INDIVIDUALS WITH SURVEILLANCE-DETECTED PANCREATIC DUCTAL ADENOCARCINOMA
19. Tu2033 GASTRIC CANCER FOLLOWING PANCREATICODUODENECTOMY: DEFINING THE INCIDENCE AND IMPACT OF DISEASE
20. 594 CLINICAL SIGNIFICANCE OF SURVEILLANCE-DETECTED DUCTAL ABNORMALITIES IN INDIVIDUALS AT HIGH RISK FOR PANCREATIC CANCER
21. 490f – Liver Cancer Organoids Model Drug Response Heterogeneity
22. 345 – Non-Selective β-Adrenergic Blockade Impacts Pancreatic Cancer Tumor Biology, Decreases Perineural Invasion and Improves Patient Survival
23. Tu1461 – Reconsidering Lymphadenectomy for Localized Pancreatic Neuroendocrine Tumors
24. 735 – Should Diffuse Main-Duct Intraductal Papillary Mucinous Neoplasms Be Treated with Total Pancreatectomy?
25. 390 – Is the New T1 Category Defined by the 8Th Edition Ajcc Pancreatic Cancer Staging System an Improvement? an Evaluation by Multinational Data
26. 490e – Complext Patient Derived Organoids(CPDOS) Modeling for Anti-Cancer Drug Screening
27. 410 - Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
28. 229 - Surgical and Patient-Centered Outcomes after Pancreatic Resection in High-Risk Individuals for Pancreatic Cancer: A 20-Year Prospective Cancer of the Pancreas Screening (CAPS) Cohort Study
29. Intraductal Papillary Mucinous Neoplasm in Patients Under age 50: Tumor Biology, Clinical Features, Recurrence Rates, and Survival Outcomes
30. A Multicenter, Validation Study of Cyst Fluid Analysis for MAB Das-1 for the Identification of High-Risk and Malignant Mucinous Cysts of the Pancreas
31. Predictors of Neoplastic Progression in High-Risk Individuals Undergoing Surveillance for Pancreatic Cancer: Lessons from the First 16 Years of the Cancer of the Pancreas Screening (CAPS) Program
32. 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts
33. AGA Guidelines for the Management of Pancreatic Cysts
34. 954 Proposal of a New Staging System for Ampulla of Vater Cancer With Higher Distinction Ability; Multinational Study From Eastern and Western
35. 490 Impact of Sarcopenia on Short- and Long-Term Outcomes in Patients Undergoing Curative Intent Resection for Pancreatic Adenocarcinoma: A New Tool
36. 381 - Intraductal Papillary Mucinous Neoplasm in Patients Under age 50: Tumor Biology, Clinical Features, Recurrence Rates, and Survival Outcomes
37. Sa1316 - Predictors of Neoplastic Progression in High-Risk Individuals Undergoing Surveillance for Pancreatic Cancer: Lessons from the First 16 Years of the Cancer of the Pancreas Screening (CAPS) Program
38. 666 - A Multicenter, Validation Study of Cyst Fluid Analysis for MAB Das-1 for the Identification of High-Risk and Malignant Mucinous Cysts of the Pancreas
39. Mo1158 The Epidemiology and Clinical Outcome of Pancreatic Solid Pseudopapillary Neoplasms: A Systematic Review
40. Management and Perioperative Morbidity Among Patients With Surgically Managed Pancreatic Adenocarcinoma: A Population-Based Analysis Using SEER-Medicare Data
41. Trends in the Palliative Surgical Management of Patients With Unresectable Pancreatic Adenocarcinoma: Lessons Learned From a Large, Single Institution Experience
42. 790 Trends in the Management and Survival of Surgically Managed Gallbladder Adenocarcinoma: A Population-Based Analysis
43. W1682 Tumor Size Correlates With Lymph Node Metastasis in Primary Pancreatic Endocrine Neoplasms
44. T1649 Safety and Efficacy of Curative Intent Surgery for Peri-Ampullary Liver Metastasis
45. T1376 Location and Size Predict Invasiveness of Pancreatic Serous Cystic Neoplasms
46. M1547 Hepatic Neuroendocrine Metastases: Intraoperative Detection of the Occult Primary Tumor
47. S2014 Age and Multifocality of Cystic Lesions Are Associated with Increased Risk of Carcinoma in Situ or Invasive Pancreatic Adenocarcinoma in Patients with High Risk Family History
48. M1592 Is There Any Role for Resection for Stage IV Gastric Cancers?
49. T1741 Risk Factors for Pancreatic Leak Following Distal Pancreatectomy
50. W1677 Incidence and Management of Chylous Leaks Following Pancreatic Resection: A High Volume Single-Center Institutional Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.